Voorbeelden van het gebruik van Foetus see in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Saquinavir should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus see section 5.3.
the patient must be informed of the potential risk to the foetus(see section 5.3)
after a careful consideration of the needs of the mother and the risk for the foetus see section 4.4.
the patient must be informed of the potential risk to the foetus(see section 5.3)
after a careful risk/benefit analysis has been conducted for both the mother and the foetus see section 5.3.
Eylea should not be used in pregnancy unless the potential benefit outweighs the potential risk to the foetus see section 4.6.
Drug could cause damage to articular cartilage in the human immature organism/ foetus see section 5.3.
Eltrombopag should be used during pregnancy only if the expected benefit justifies the potential risk to the foetus see section 4.6.
the patient must be advised of the significant teratogenic risk of ribavirin to the foetus see section 4.4.
In juvenile and prenatal animals exposed to quinolones, effects on immature cartilage have been observed, thus, it cannot be excluded that the drug could cause damage to articular cartilage in the human immature organism/ foetus see section 5.3.
the patient should be informed of the potential hazard to the foetus see section 5.3.
In case pregnancy should occur during treatment with Jakavi, a risk/benefit evaluation must be carried out on an individual basis with careful counselling regarding potential risks to the foetus see section 5.3.
The use of lutetium(177Lu)-labelled medicinal products is contraindicated during established or suspected pregnancy or when pregnancy has not been excluded due to the risk of ionizing radiation to the foetus see section 4.3.
Osigraft should not be used during pregnancy unless the potential benefit justifies the potential risks to the foetus see sections 4.4 and 5.3.
Animal studies revealed no adverse effects on fertility apart from a slight reduction in implantations and viable foetuses see section 5.3.
Vemurafenib revealed no evidence of teratogenicity in rat or rabbit embryo/foetuses see section 5.3.
Some Ichthyosaur fossils are so well preserved that we can actually see foetuses inside the mother's bodies,